tocilizumab; COVID-19

  1. Home
  2. Posts tagged “tocilizumab; COVID-19”
Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial
By MediSys Research Admin
June 30, 2022
122 Views
Publish Work

Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial

Recent Posts
The UCI EyeMobile Preschool Vision Screening Program: Refractive Error and Amblyopia Results from the 2019–2020 School Year
March 27, 2023
An Infected, Noncoronary, Bare Metal Stent Presenting as a Right Groin Abscess
March 27, 2023
A Case of Necrotizing Fasciitis Mimicking a Burn in an Elderly Patient
March 27, 2023
Closed-Loop Gastric Outlet Obstruction Secondary to Duodenal Ulcer in a Patient With Esophageal Stricture
March 27, 2023
Chasing the Dragon
November 3, 2022
Metagenomic Sequencing of the Gallbladder Microbiome: Bacterial Diversity Does Not Vary by Surgical Pathology
October 27, 2022
The patient behind the wound assessment and plan
October 27, 2022
Physiology, Central Venous Pressure
October 27, 2022
A feeding jejunostomy causing an intussusception - case report and literature review
October 27, 2022
Neuroleptic Malignant Syndrome From Oxcarbazepine and Topiramate Withdrawal: An Unusual Case
October 27, 2022